![]() |
![]() |
May 2005, Volume 4 Published by the National Cancer Institute's Center for Cancer Research |
![]() |
A Novel HIF-1α-Myc Pathway Regulating Hypoxia-induced Cell-cycle Arrest
HIF-1α expression is regulated primarily by posttranslational stabilization, resulting from inhibition of the ubiquitin-proteasome pathway that targets the oxygen-dependent degradation domain (ODD) of HIF-1α. HIF prolyl 4-hydroxylases function as oxygen sensors to modify two proline residues within the ODD, thereby enabling the VHL E3 ubiquitin ligase to bind specifically to the hydroxyprolines for HIF-1α polyubiquitination. Accordingly, deletion of the ODD renders HIF-1α stable and capable of binding the hypoxia-responsive element (HRE) and activating the downstream target genes. Interestingly, apart from stimulation of angiogenesis and glycolysis for cell proliferation and survival, hypoxia also induces cell-cycle arrest, apparently against tumor development. Although the results from Hif1α-null cells indicate that HIF-1α is required for hypoxia-induced upregulation of p21cip1, a key cyclin-dependent kinase inhibitor that controls the G1 checkpoint, the role of HIF-1α in the cell cycle remained controversial. Moreover, it remained obscure how HIF-1α transcriptionally activates p21cip1 due to the lack of HIF-1α-bound HRE in the promoter. ...we validated that the N-terminal HIF-1α is critical for cell-cycle arrest, indicating a novel mechanism for HIF-1α function. To provide direct evidence that HIF-1α controls the cell cycle, we took advantage of an ODD-deficient HIF-1α and demonstrated that expression of HIF-1α in normoxia is sufficient to induce G1 arrest. As expected, HIF-1α activates p21cip1 expression, and conversely, HIF-1αinduced cell-cycle arrest is p21cip1 dependent. Therefore, HIF-1α induces G1 arrest via the activation of p21cip1. To understand the mechanism underlying p21cip1 activation in hypoxia, we created two functional mutations that inactivate HIF-1α DNA-binding and transcriptional activation, respectively. To our surprise, both mutants were still able to activate p21cip1 and to cause G1 arrest, despite their inability to upregulate known HIF-1α target genes, such as VEGF. Thus, neither HIF-1 transcriptional activity nor its DNA binding is required for p21cip1 activation, implying a novel HIF-1α function in regulating gene expression. In pursuit of the distinct function of HIF-1α, we hypothesized that HIF-1α upregulates p21cip1 by virtue of functionally counteracting Myc, a known repressor that binds the transcription activator Miz-1 of p21cip1. Consistently, hypoxic treatment or HIF-1α expression in normoxia overrode Myc-targeted gene expression; hypoxia/HIF-1α not only upregulated Myc-repressed gene p21cip1, but also downregulated Myc-activated genes, such as TERT and BRCA1. RNA silencing experiments demonstrated a critical role for Myc in HIF-1α action. Moreover, chromatin immunoprecipitation analysis of the p21cip1 promoter showed that Myc binding was markedly weakened by hypoxia or HIF-1α, suggesting that the HIF-1α action is mediated by the displacement of Myc from the p21cip1 promoter. We showed further that HIF-1α forms a weak complex with Myc. The protein-protein interaction is mediated by an HIF-1α N-terminal region consisting of bHLH and PAS domains. Finally, we validated that the N-terminal HIF-1α is critical for cell-cycle arrest, indicating a novel mechanism for HIF-1α function. This study has demonstrated that HIF-1α employs at least two mechanisms for regulating gene expression: in addition to the classical mode of action involving binding to the HRE plus transactivation via transcriptional activation domains, HIF-1α functionally antagonizes Myc via its N-terminal region to override the expression of Myc-targeted genes that lack a canonical HRE. This new pathway may signify a new set of hypoxia-responsive genes that cannot be accounted for by the previously identified mechanisms. In addition, the independent action of HIF-1α N-terminal indicates that HIF-1α polypeptide, devoid of transactivation domains and DNA binding activity, is in fact functional; HIF-1α mutants in this nature are still able to regulate hypoxia-responsive genes that lack HREs. Therefore, the interpretation of effects of such “dominant-negative” mutants may need to be reevaluated. |